457 related articles for article (PubMed ID: 20674009)
1. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
3. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles.
He Q; Shi J; Chen F; Zhu M; Zhang L
Biomaterials; 2010 Apr; 31(12):3335-46. PubMed ID: 20106517
[TBL] [Abstract][Full Text] [Related]
4. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
5. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
6. Loading of polymyxin B onto anionic mesoporous silica nanoparticles retains antibacterial activity and enhances biocompatibility.
Gounani Z; Asadollahi MA; Meyer RL; Arpanaei A
Int J Pharm; 2018 Feb; 537(1-2):148-161. PubMed ID: 29278732
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
8. A robust graft-to strategy to form multifunctional and stealth zwitterionic polymer-coated mesoporous silica nanoparticles.
Zhu Y; Sundaram HS; Liu S; Zhang L; Xu X; Yu Q; Xu J; Jiang S
Biomacromolecules; 2014 May; 15(5):1845-51. PubMed ID: 24670217
[TBL] [Abstract][Full Text] [Related]
9. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
10. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.
Quan G; Pan X; Wang Z; Wu Q; Li G; Dian L; Chen B; Wu C
J Nanobiotechnology; 2015 Feb; 13():7. PubMed ID: 25643602
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
12. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
13. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
14. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
[TBL] [Abstract][Full Text] [Related]
15. Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4.
Kwon D; Cha BG; Cho Y; Min J; Park EB; Kang SJ; Kim J
Nano Lett; 2017 May; 17(5):2747-2756. PubMed ID: 28422506
[TBL] [Abstract][Full Text] [Related]
16. Salvianolic acid B-loaded polydopamine-modified hollow mesoporous organic silica nanoparticles for treatment of breast cancer metastasis via suppressing cancer-associated fibroblasts.
Hu M; Cheng N; Wang S; Li R; Liu Y; Wang L; Chen W; Chen Y
Eur J Pharm Sci; 2024 Jan; 192():106641. PubMed ID: 37972905
[TBL] [Abstract][Full Text] [Related]
17. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
18. Molecular Elucidation of Biological Response to Mesoporous Silica Nanoparticles in Vitro and in Vivo.
Chou CC; Chen W; Hung Y; Mou CY
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22235-22251. PubMed ID: 28608695
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Liu G; Zheng D; Tian X
Int J Pharm; 2013 Mar; 445(1-2):12-9. PubMed ID: 23384728
[TBL] [Abstract][Full Text] [Related]
20. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]